In vitro and in vivo experiments have both suggested a pro-oncogenic role for HDAC9 in GC, as HDAC9 knockdown resulted in reduced GC tumor growth and the induction of GC cell apoptosis and proliferation. The gene discussed is HDAC9; the disease is neoplasm.